Exciting new project with the Pharmaceutical Press (PhP)

Expressions of interest:

We are currently seeking expressions of interest to support an exciting new project with the Pharmaceutical Press (PhP).

PhP is developing a new resource to support healthcare professionals in the management of patients with impaired renal function. As part of this project, content relating to cancer drugs is being created.

We are looking for experienced oncology and haematology pharmacists to peer review SACT related content produced by our in house writers, to help ensure that the monographs are accurate and reflective of real life clinical practice.

This is an unpaid, voluntary role involving the review of approximately 4–5 drug monographs over the course of a year, with an estimated time commitment of 2-3 hours per month. While the role is voluntary, all contributions are greatly appreciated, and reviewers will be acknowledged in the editorial section of the resource.

If this opportunity is of interest, please contact Alex McPhail ([email protected]) at PhP for further information.

Thank you for your time and consideration.

Kind regards,
Sent on behalf of The Pharmaceutical Press

Alex McPhail, Content Manager (New Products)
Direct +44 (0)20 7572 2234 | Email [email protected] 
Pharmaceutical Press, 66-68 East Smithfield, London, E1W 1AW, UK

Latest News

By BOPA Research Subcommittee on 15th June 2026

Deadline EXTENDED: Abstract Submission for #BOPA2026

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN   Deadline for Abstract Submission for the 29th Annual BOPA Conference 2026 has been EXTENDED! Don’t miss the…

Read article
By BOPA on 15th June 2026

The BOPA Training and Development Grant – BOPA Conference 2026

BOPA are offering (in collaboration with Gilead) 16 funded places to the BOPA 2026 Conference in London from 2-4th Oct 20265. Information can be found here – The BOPA Training and Development Grant…

Read article
By BOPA Education & Training Subcommittee on 12th June 2026

BOPA Publication – Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative  The study explored factors influencing cancer pharmacists’ progression through…

Read article
By BOPA AI Cancer Advisory Group on 12th June 2026

BOPA AI CAG contribute to the National Commission into the Regulation of AI in Healthcare: research, engagement and call for evidence findings

Recently, the MHRA invited feedback from individuals and organisations on the regulation of AI in healthcare across the UK. The BOPA AI CAG responded to this call for evidence, and…

Read article